Drug Profile
Ulobetasol lotion - Therapeutics Incorporated
Alternative Names: 000-0551; Halobetasol lotion - Therapeutics IncorporatedLatest Information Update: 13 Apr 2016
Price :
$50
*
At a glance
- Originator Therapeutics Incorporated
- Class Anti-inflammatories; Antiallergics; Antipsoriatics; Corticosteroids; Skin disorder therapies; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Plaque psoriasis
Most Recent Events
- 13 Apr 2016 No recent reports on development identified - Phase-III for Plaque psoriasis in USA (Topical)
- 01 Mar 2014 Therapeutics Incorporated completes a phase III trial in Plaque psoriasis in USA (NCT01882647)
- 31 Dec 2013 Therapeutics Incorporated completes a phase III trial for Plaque psoriasis in USA (NCT01871402)